PFIZER
Back to Balance Sheet
|
PFIZER Last 5 Year Total Current Liabilities History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹627 Cr | ₹570 Cr | ₹547 Cr | ₹657 Cr | ₹853 Cr |
What is the latest Total Current Liabilities ratio of PFIZER ?
| Year | Total Current Liabilities |
|---|---|
| Mar2026 | ₹627 Cr |
| Mar2025 | ₹570 Cr |
| Mar2024 | ₹547 Cr |
| Mar2023 | ₹657 Cr |
| Mar2022 | ₹853 Cr |
How is Total Current Liabilities of PFIZER Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹627 Cr | 10.18 | |
| Mar2025 | ₹570 Cr | 4.20 | |
| Mar2024 | ₹547 Cr | -16.85 | |
| Mar2023 | ₹657 Cr | -22.93 | |
| Mar2022 | ₹853 Cr | - | |
Compare Total Current Liabilities of peers of PFIZER
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PFIZER | ₹18,304.2 Cr | -0.8% | -16.5% | -20.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹444,717.0 Cr | -0.8% | -2.5% | 11.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹255,115.0 Cr | 1.9% | 6.6% | 55.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,613.0 Cr | 0.3% | 2% | 35.9% | Stock Analytics | |
| CIPLA | ₹112,876.0 Cr | 0.9% | -0.8% | -10.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,395.0 Cr | 0.1% | 1.4% | -9.3% | Stock Analytics | |
PFIZER Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PFIZER | -0.8% |
-16.5% |
-20.8% |
| SENSEX | -0.5% |
-4.8% |
-11% |
You may also like the below Video Courses